Calendar

pharmadog

Week of Nov 10, 2025

Nov 13, 2025approval289d agoNALBUPHINE HYDROCHLORIDE — FDA approvalNALBUPHINE HYDROCHLORIDE

Sponsor: RISING. Form: SOLUTION. Route: INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS

full page →NALBUPHINE HYDROCHLORIDE →fda approvals ↗

Nov 13, 2025approval289d agoATORVASTATIN CALCIUM — FDA approvalViatris Inc

Sponsor: TEVA PHARMS INC. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Nov 13, 2025approval289d agoVERAPAMIL HYDROCHLORIDE — FDA approvalCalan

Sponsor: ASPIRO. Form: INJECTABLE. Route: INJECTION

full page →Calan →fda approvals ↗

Nov 13, 2025approval289d agoKOMZIFTI (ZIFTOMENIB) — FDA approvalKura Oncology, Inc.

Sponsor: KURA. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Nov 13, 2025approval289d agoONDANSETRON — FDA approvalSandoz Inc

Sponsor: IPCA LABS LTD. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL

full page →fda approvals ↗

Nov 13, 2025approval289d agoONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE (ONDANSETRON HYDROCHLORIDE) — FDA approvalondansetron hydrochloride CR

Sponsor: ACCORD HLTHCARE. Form: INJECTABLE. Route: INJECTION

full page →ondansetron hydrochloride CR →fda approvals ↗

Nov 13, 2025approval289d agoBRIVARACETAM — FDA approvalBRIVARACETAM

Sponsor: MSN. Form: TABLET. Route: ORAL

full page →BRIVARACETAM →fda approvals ↗

Nov 13, 2025approval289d agoPOHERDY (PERTUZUMAB-DPZB) — FDA approvalpertuzumab biosimilar

Sponsor: SHANGHAI HENLIUS BIOTECH. Form: INJECTABLE. Route: INTRAVENOUS

full page →pertuzumab biosimilar →fda approvals ↗

Nov 13, 2025approval289d agoLEUPROLIDE ACETATE — FDA approvalZydus Therapeutics Inc

Sponsor: ZYDUS PHARMS. Form: SOLUTION. Route: SUBCUTANEOUS

full page →fda approvals ↗

Nov 13, 2025approval289d agoONDANSETRON — FDA approvalSandoz Inc

Sponsor: BARR. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL

full page →fda approvals ↗

Nov 13, 2025approval289d agoRALDESY (TRAZODONE HYDROCHLORIDE) — FDA approvalTeva Pharmaceuticals USA Inc

Sponsor: KAMAT. Form: SOLUTION. Route: ORAL

full page →fda approvals ↗

Nov 13, 2025approval289d agoIOHEXOL — FDA approvalIOHEXOL

Sponsor: AMNEAL. Form: SOLUTION. Route: INJECTION, ORAL, RECTAL

full page →IOHEXOL →fda approvals ↗

Nov 14, 2025approval288d agoDANZITEN (NILOTINIB TARTRATE) — FDA approvalDANZITEN

Sponsor: AZURITY. Form: TABLET. Route: ORAL

full page →DANZITEN →fda approvals ↗

Nov 14, 2025approval288d agoDARZALEX FASPRO (DARATUMUMAB AND HYALURONIDASE-FIHJ) — FDA approval(daratumumab + hyaluronidase (human recombinant))

Sponsor: JANSSEN BIOTECH. Form: INJECTABLE. Route: INJECTION

full page →(daratumumab + hyaluronidase (human recombinant)) →fda approvals ↗

Nov 14, 2025approval288d agoALDACTAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

Sponsor: PFIZER. Form: TABLET. Route: ORAL

full page →ALDACTAZIDE →fda approvals ↗

Nov 14, 2025approval288d agoLUPRON DEPOT-PED KIT (LEUPROLIDE ACETATE) — FDA approvalAmneal Pharmaceuticals, Inc.

Sponsor: ABBVIE ENDOCRINE INC. Form: POWDER. Route: INTRAMUSCULAR

full page →fda approvals ↗

Nov 14, 2025approval288d agoARIPIPRAZOLE — FDA approvalTeva Pharmaceuticals USA Inc

Sponsor: TEVA PHARMS USA. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Nov 14, 2025approval288d agoARIPIPRAZOLE — FDA approvalTeva Pharmaceuticals USA Inc

Sponsor: TEVA PHARMS USA. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Nov 14, 2025approval288d agoARIPIPRAZOLE — FDA approvalTeva Pharmaceuticals USA Inc

Sponsor: TEVA PHARMS USA. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Nov 14, 2025approval288d agoARIPIPRAZOLE — FDA approvalTeva Pharmaceuticals USA Inc

Sponsor: TEVA PHARMS USA. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Nov 14, 2025approval288d agoARIPIPRAZOLE — FDA approvalTeva Pharmaceuticals USA Inc

Sponsor: TEVA PHARMS USA. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Nov 14, 2025approval288d agoARIPIPRAZOLE — FDA approvalTeva Pharmaceuticals USA Inc

Sponsor: TEVA PHARMS USA. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Nov 14, 2025approval288d agoARIPIPRAZOLE — FDA approvalTeva Pharmaceuticals USA Inc

Sponsor: TEVA PHARMS USA. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Nov 14, 2025approval288d agoARIPIPRAZOLE — FDA approvalTeva Pharmaceuticals USA Inc

Sponsor: TEVA PHARMS USA. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Nov 14, 2025approval288d agoARIPIPRAZOLE — FDA approvalTeva Pharmaceuticals USA Inc

Sponsor: TEVA PHARMS USA. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Nov 14, 2025approval288d agoARIPIPRAZOLE — FDA approvalTeva Pharmaceuticals USA Inc

Sponsor: TEVA PHARMS USA. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Nov 14, 2025approval288d agoARIPIPRAZOLE — FDA approvalTeva Pharmaceuticals USA Inc

Sponsor: TEVA PHARMS USA. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Nov 14, 2025approval288d agoARIPIPRAZOLE — FDA approvalTeva Pharmaceuticals USA Inc

Sponsor: TEVA PHARMS USA. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Nov 14, 2025approval288d agoDIAZEPAM — FDA approvalDIAZEPAM

Sponsor: NAVINTA LLC. Form: GEL. Route: RECTAL

full page →DIAZEPAM →fda approvals ↗

Nov 14, 2025approval288d agoLENALIDOMIDE — FDA approvalLENALIDOMIDE

Sponsor: ACCORD HLTHCARE. Form: CAPSULE. Route: ORAL

full page →LENALIDOMIDE →fda approvals ↗

Nov 14, 2025approval288d agoDIPHENHYDRAMINE HYDROCHLORIDE — FDA approvalPAI Holding Co LLC

Sponsor: AVET LIFESCIENCES. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Nov 14, 2025approval288d agoARIPIPRAZOLE — FDA approvalTeva Pharmaceuticals USA Inc

Sponsor: TEVA PHARMS USA. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Nov 14, 2025approval288d agoARIPIPRAZOLE — FDA approvalTeva Pharmaceuticals USA Inc

Sponsor: TEVA PHARMS USA. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Nov 14, 2025approval288d agoARIPIPRAZOLE — FDA approvalTeva Pharmaceuticals USA Inc

Sponsor: TEVA PHARMS USA. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Nov 14, 2025approval288d agoARIPIPRAZOLE — FDA approvalTeva Pharmaceuticals USA Inc

Sponsor: TEVA PHARMS USA. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Nov 14, 2025approval288d agoARIPIPRAZOLE — FDA approvalTeva Pharmaceuticals USA Inc

Sponsor: TEVA PHARMS USA. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Nov 14, 2025approval288d agoARIPIPRAZOLE — FDA approvalTeva Pharmaceuticals USA Inc

Sponsor: TEVA PHARMS USA. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Nov 14, 2025approval288d agoFOSFOMYCIN TROMETHAMINE — FDA approvalFOSFOMYCIN TROMETHAMINE

Sponsor: AUROBINDO PHARMA LTD. Form: FOR SOLUTION. Route: ORAL

full page →FOSFOMYCIN TROMETHAMINE →fda approvals ↗

Nov 14, 2025approval288d agoALDACTONE (SPIRONOLACTONE) — FDA approvalALDACTONE

Sponsor: PFIZER. Form: TABLET. Route: ORAL

full page →ALDACTONE →fda approvals ↗

Nov 14, 2025approval288d agoDILTIAZEM HYDROCHLORIDE — FDA approvalDILTIAZEM HYDROCHLORIDE

Sponsor: ALEMBIC. Form: TABLET. Route: ORAL

full page →DILTIAZEM HYDROCHLORIDE →fda approvals ↗

Nov 14, 2025approval288d agoOXYCODONE HYDROCHLORIDE — FDA approvalOXYCODONE HYDROCHLORIDE

Sponsor: ASCENT PHARMS INC. Form: TABLET. Route: ORAL

full page →OXYCODONE HYDROCHLORIDE →fda approvals ↗

Nov 14, 2025approval288d agoVORICONAZOLE — FDA approvalVORICONAZOLE

Sponsor: HAINAN POLY PHARM. Form: SOLUTION. Route: INTRAVENOUS

full page →VORICONAZOLE →fda approvals ↗

Nov 14, 2025approval288d agoRIVAROXABAN — FDA approvalRIVAROXABAN

Sponsor: APOTEX. Form: TABLET. Route: ORAL

full page →RIVAROXABAN →fda approvals ↗

Nov 14, 2025approval288d agoTRUQAP (CAPIVASERTIB) — FDA approvalcapivasertib

Sponsor: ASTRAZENECA. Form: TABLET. Route: ORAL

full page →capivasertib →fda approvals ↗

Week of Nov 17, 2025

Nov 17, 2025approval285d agoOXYMORPHONE HYDROCHLORIDE — FDA approvalOXYMORPHONE HYDROCHLORIDE

Sponsor: EPIC PHARMA LLC. Form: TABLET. Route: ORAL

full page →OXYMORPHONE HYDROCHLORIDE →fda approvals ↗

Nov 17, 2025approval

← prev

page 342 of 380

Week of Nov 10, 2025

Week of Nov 17, 2025